VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
WLKPWestlake Chemical Partners LP
$22.60$797M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

WLKP logoWestlake Chemical Partners LP(WLKP)Earnings, Financials & Key Ratios

WLKP•NYSE
2.7× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustryChemicalsSub-IndustryPetrochemicals, plastics and oxygenates
AboutWestlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.Show more
  • Revenue$1.17B+2.7%
  • EBITDA$448M-10.9%
  • Net Income$299M+378.5%
  • EPS (Diluted)8.47+378.5%
  • Gross Margin29.81%-19.2%
  • EBITDA Margin38.36%-13.3%
  • Operating Margin27.39%-20.3%
  • Net Margin25.59%+365.9%
  • ROE36.6%+394.4%

WLKP Key Insights

Westlake Chemical Partners LP (WLKP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 35.2%
  • ✓FCF machine: 17.3% free cash flow margin
  • ✓Good 3Y average ROE of 16.7%
  • ✓Trading at only 1.0x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when WLKP posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

WLKP Price & Volume

Westlake Chemical Partners LP (WLKP) stock price & volume — 10-year historical chart

Loading chart...

WLKP Growth Metrics

Westlake Chemical Partners LP (WLKP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.48%
5 Years3.83%
3 Years-9.86%
TTM13.4%

Profit CAGR

10 Years22.32%
5 Years35.17%
3 Years66.94%
TTM271.62%

EPS CAGR

10 Years19.14%
5 Years35.13%
3 Years66.96%
TTM142.95%

Return on Capital

10 Years26.95%
5 Years28.38%
3 Years28.48%
Last Year26.22%

WLKP Recent Earnings

Westlake Chemical Partners LP (WLKP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.40-7.0%
$0.43
Rev
$306M-41.4%
$522M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.41+8.2%
$0.38
Rev
$323M+3.2%
$313M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.42-2.3%
$0.43
Rev
$309M+1.9%
$303M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.41-7.7%
$0.44
Rev
$297M-1.3%
$301M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.40vs $0.43-7.0%
$306Mvs $522M-41.4%
Q1 2026Feb 24, 2026
$0.41vs $0.38+8.2%
$323Mvs $313M+3.2%
Q4 2025Oct 30, 2025
$0.42vs $0.43-2.3%
$309Mvs $303M+1.9%
Q3 2025Aug 5, 2025
$0.41vs $0.44-7.7%
$297Mvs $301M-1.3%
Based on last 12 quarters of dataView full earnings history →

WLKP Peer Comparison

Westlake Chemical Partners LP (WLKP) competitors in Petrochemicals, plastics and oxygenates — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
MPLX logoMPLXMPLX LpDirect Competitor57.7B56.8411.798.37%37.54%32.81%1.80
HESM logoHESMHess Midstream LPDirect Competitor7.67B36.7912.868.67%21.79%74.89%8.61
CAPL logoCAPLCrossAmerica Partners LPDirect Competitor839.73M22.0220.20-10.63%2.03%
WLK logoWLKWestlake CorporationProduct Competitor10.28B80.28-6.84-8.01%-14.91%-16.76%0.69
OLN logoOLNOlin CorporationProduct Competitor2.51B22.01-59.493.68%-1.89%-6.64%1.76
CE logoCECelanese CorporationProduct Competitor5.73B51.16-4.81-7.16%-10.79%-21.51%2.89
TROX logoTROXTronox Holdings plcProduct Competitor1.18B7.40-2.49-5.73%-12.3%-30.42%2.48
ETH logoETHGrayscale Ethereum Mini Trust ETFSupply Chain415.27M16.218.06-4.89%7.35%9.21%0.26

Compare WLKP vs Peers

Westlake Chemical Partners LP (WLKP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MPLX

Most directly comparable listed peer for WLKP.

Scale Benchmark

vs EPD

Larger-name benchmark to compare WLKP against a more recognizable public peer.

Peer Set

Compare Top 5

vs MPLX, HESM, CAPL, WLK

WLKP Income Statement

Westlake Chemical Partners LP (WLKP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
1.17B1.29B1.09B966.67M1.21B1.59B1.19B1.14B1.17B1.23B
Revenue Growth %
18.87%9.6%-15.07%-11.47%25.67%31.14%-25.26%-4.61%2.71%13.4%
Cost of Goods Sold
769.31M908.46M712.44M587.79M773.15M1.22B803.33M716.96M818.85M847.22M
COGS % of Revenue
65.59%70.66%65.25%60.81%63.64%76.31%67.46%63.12%70.19%-
Gross Profit
403.67M▲ 0%
377.16M▼ 6.6%
379.43M▲ 0.6%
378.88M▼ 0.1%
441.71M▲ 16.6%
377.37M▼ 14.6%
387.46M▲ 2.7%
418.94M▲ 8.1%
347.85M▼ 17.0%
387.53M▲ 0%
Gross Margin %
34.41%29.34%34.75%39.19%36.36%23.69%32.54%36.88%29.81%31.39%
Gross Profit Growth %
3.15%-6.57%0.6%-0.14%16.58%-14.57%2.67%8.12%-16.97%-
Operating Expenses
29.26M27.59M29.28M25.89M31.02M29.68M29.75M28.5M28.27M27.99M
OpEx % of Revenue
2.49%2.15%2.68%2.68%2.55%1.86%2.5%2.51%2.42%-
Selling, General & Admin
29.26M27.59M29.28M25.89M31.02M29.68M29.75M28.5M28.27M27.99M
SG&A % of Revenue
2.49%2.15%2.68%2.68%2.55%1.86%2.5%2.51%2.42%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
0000000000
Operating Income
374.41M▲ 0%
349.57M▼ 6.6%
350.15M▲ 0.2%
352.99M▲ 0.8%
410.69M▲ 16.3%
347.69M▼ 15.3%
357.71M▲ 2.9%
390.44M▲ 9.2%
319.58M▼ 18.2%
359.54M▲ 0%
Operating Margin %
31.92%27.19%32.07%36.52%33.81%21.82%30.04%34.37%27.39%29.12%
Operating Income Growth %
2.17%-6.63%0.17%0.81%16.35%-15.34%2.88%9.15%-18.15%-
EBITDA
488.39M458.41M457.47M456.14M519.5M468.76M467.91M502.34M447.56M465.71M
EBITDA Margin %
41.64%35.66%41.9%47.19%42.76%29.42%39.29%44.22%38.36%37.72%
EBITDA Growth %
5.11%-6.14%-0.21%-0.29%13.89%-9.77%-0.18%7.36%-10.91%6.92%
D&A (Non-Cash Add-back)
113.98M108.84M107.32M103.15M108.81M121.07M110.2M111.9M127.98M106.17M
EBIT
376.2M352.03M353.25M353.72M410.75M349.25M361.94M395.69M322.02M360.64M
Net Interest Income
-21.86M-21.43M-19.62M-12.04M-8.82M-13.41M-26.5M-25.7M-22.9M-40.25M
Interest Income
0000000000
Interest Expense
21.86M21.43M19.62M12.04M8.82M13.41M26.5M25.7M22.9M35.16M
Other Income/Expense
-20.07M-18.98M-16.53M-11.3M-8.75M-11.84M-22.27M-20.45M-20.45M-21M
Pretax Income
354.34M▲ 0%
330.59M▼ 6.7%
333.62M▲ 0.9%
341.68M▲ 2.4%
401.93M▲ 17.6%
335.85M▼ 16.4%
335.44M▼ 0.1%
369.99M▲ 10.3%
299.12M▼ 19.2%
338.54M▲ 0%
Pretax Margin %
30.21%25.71%30.56%35.35%33.08%21.08%28.17%32.57%25.64%27.42%
Income Tax
1.28M22K728K564K549K1.02M813K835K547K617K
Effective Tax Rate %
0.36%0.01%0.22%0.17%0.14%0.3%0.24%0.23%0.18%0.18%
Net Income
48.67M▲ 0%
49.35M▲ 1.4%
60.98M▲ 23.6%
66.17M▲ 8.5%
82.55M▲ 24.8%
64.17M▼ 22.3%
54.28M▼ 15.4%
62.39M▲ 14.9%
298.58M▲ 378.5%
195.12M▲ 0%
Net Margin %
4.15%3.84%5.58%6.84%6.79%4.03%4.56%5.49%25.59%15.8%
Net Income Growth %
18.88%1.39%23.58%8.5%24.76%-22.26%-15.41%14.94%378.55%271.62%
Net Income (Continuing)
353.06M330.57M332.89M341.12M401.38M334.83M334.63M369.16M298.58M337.92M
Discontinued Operations
0000000000
Minority Interest
778.93M718.27M432.05M395.17M436.15M369.21M333.74M310.61M301.24M293.72M
EPS (Diluted)
1.72▲ 0%
1.51▼ 12.2%
1.77▲ 17.2%
1.88▲ 6.2%
2.34▲ 24.5%
1.82▼ 22.2%
1.54▼ 15.4%
1.77▲ 14.9%
8.47▲ 378.5%
5.51▲ 0%
EPS Growth %
117.72%-12.21%17.22%6.21%24.47%-22.22%-15.38%14.94%378.53%142.95%
EPS (Basic)
1.721.531.771.882.341.821.541.778.47-
Diluted Shares Outstanding
28.39M32.68M34.49M35.2M35.21M35.22M35.22M35.23M35.23M35.42M
Basic Shares Outstanding
28.39M32.24M34.49M35.2M35.21M35.22M35.25M35.23M35.23M35.42M
Dividend Payout Ratio
86.54%108.14%101.81%100.3%80.41%103.49%122.36%106.48%22.26%-

WLKP Balance Sheet

Westlake Chemical Partners LP (WLKP) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
231.39M247.14M238.41M263.31M281.21M245.79M226.2M240.93M143.51M148.9M
Cash & Short-Term Investments
27.01M19.74M19.92M17.15M17.06M64.78M58.62M58.32M44.27M44.29M
Cash Only
27.01M19.74M19.92M17.15M17.06M64.78M58.62M58.32M44.27M44.29M
Short-Term Investments
0000000000
Accounts Receivable
198.48M222.64M214.94M242.28M254.86M109.5M162.71M178.11M63.57M45.08M
Days Sales Outstanding
61.7663.2171.8591.4876.5725.0949.8757.2319.8923.24
Inventory
5.59M4.39M2.48M3.47M8.9M4.71M4.43M4.06M2.77M3.09M
Days Inventory Outstanding
2.651.761.272.164.21.422.012.071.231.31
Other Current Assets
001.07M392K396K66.49M442K444K32.9M56.44M
Total Non-Current Assets
1.28B1.21B1.16B1.09B1.2B1.13B1.09B1.05B1.11B1.09B
Property, Plant & Equipment
1.2B1.15B1.1B1.05B1.04B990.21M943.84M903.59M886.01M871.61M
Fixed Asset Turnover
0.98x1.12x0.99x0.92x1.16x1.61x1.26x1.26x1.32x1.39x
Goodwill
5.81M5.81M5.81M5.81M5.81M5.81M5.81M5.81M05.81M
Intangible Assets
0000000000
Long-Term Investments
-8.03M-7.48M00000000
Other Non-Current Assets
87.64M66.72M46.24M36.69M150.13M130.16M140.98M137.63M227.01M209.38M
Total Assets
1.52B▲ 0%
1.46B▼ 3.5%
1.39B▼ 4.7%
1.36B▼ 2.7%
1.48B▲ 9.2%
1.37B▼ 7.3%
1.32B▼ 4.0%
1.29B▼ 2.2%
1.26B▼ 2.4%
1.24B▲ 0%
Asset Turnover
0.77x0.88x0.78x0.71x0.82x1.16x0.90x0.88x0.93x0.97x
Asset Growth %
-2.57%-3.51%-4.7%-2.65%9.16%-7.34%-4.02%-2.19%-2.44%-12.65%
Total Current Liabilities
40.24M48.77M38.85M39.75M106.8M66.94M56.34M55.37M51.3M40.79M
Accounts Payable
24.54M32.52M21.34M20.99M45.9M49.4M31.36M20.74M51.3M40.79M
Days Payables Outstanding
11.6413.0710.9313.0321.6714.8314.2510.5622.8716.35
Short-Term Debt
0000000000
Deferred Revenue (Current)
0000000000
Other Current Liabilities
0014.9M12.56M60.9M2.65M5.47M17.71M00
Current Ratio
5.75x5.07x6.14x6.62x2.63x3.67x4.02x4.35x2.80x3.65x
Quick Ratio
5.61x4.98x6.07x6.54x2.55x3.60x3.94x4.28x2.74x3.57x
Cash Conversion Cycle
52.7751.9162.1980.6159.111.6737.6448.74-1.748.2
Total Non-Current Liabilities
476.29M479.27M402.47M401.6M401.2M401.33M404.26M403.27M402.88M402.52M
Long-Term Debt
473.96M477.61M399.67M399.67M399.67M399.67M399.67M399.67M399.67M399.67M
Capital Lease Obligations
0000000000
Deferred Tax Liabilities
2.22M1.66M1.65M1.54M1.53M01.63M1.55M04.62M
Other Non-Current Liabilities
107K01.15M381K01.66M2.95M2.05M3.21M0
Total Liabilities
516.53M528.04M441.32M441.35M508M468.27M460.59M458.64M454.18M443.31M
Total Debt
473.96M477.61M399.67M399.67M399.67M399.67M399.67M399.67M399.67M399.67M
Net Debt
446.95M457.86M379.75M382.52M382.62M334.89M341.06M341.36M355.4M355.38M
Debt / Equity
0.27x0.29x0.42x0.44x0.41x0.44x0.47x0.48x0.50x0.50x
Debt / EBITDA
0.97x1.04x0.87x0.88x0.77x0.85x0.85x0.80x0.89x0.86x
Net Debt / EBITDA
0.92x1.00x0.83x0.84x0.74x0.71x0.73x0.68x0.79x0.76x
Interest Coverage
17.21x16.42x18.00x29.38x46.59x26.05x13.66x15.40x14.06x10.26x
Total Equity
1.78B▲ 0%
1.65B▼ 7.1%
952.13M▼ 42.4%
915.14M▼ 3.9%
972.7M▲ 6.3%
903.71M▼ 7.1%
856.25M▼ 5.3%
829.31M▼ 3.1%
802.35M▼ 3.3%
792.39M▲ 0%
Equity Growth %
2.2%-7.05%-42.38%-3.89%6.29%-7.09%-5.25%-3.15%-3.25%-7.95%
Book Value per Share
62.6150.5627.6126.0027.6325.6624.3123.5422.7722.37
Total Shareholders' Equity
998.75M934.08M520.09M519.97M536.55M534.5M522.51M518.7M501.11M498.66M
Common Stock
461.49M458.38M520.09M519.97M536.55M534.5M522.51M518.7M501.11M498.66M
Retained Earnings
0000000000
Treasury Stock
0000000000
Accumulated OCI
279K000000000
Minority Interest
778.93M718.27M432.05M395.17M436.15M369.21M333.74M310.61M301.24M293.72M

WLKP Cash Flow Statement

Westlake Chemical Partners LP (WLKP) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
537.36M436.15M450.81M373.4M408.44M463.74M452M485M280.47M344.89M
Operating CF Margin %
45.81%33.93%41.29%38.63%33.62%29.11%37.96%42.7%24.04%-
Operating CF Growth %
86.76%-18.83%3.36%-17.17%9.38%13.54%-2.53%7.3%-42.17%22.5%
Net Income
353.06M330.57M332.89M341.12M401.38M334.83M54.28M369.16M298.58M195.12M
Depreciation & Amortization
113.98M108.84M107.32M103.15M108.81M121.07M110.2M111.9M127.98M135.21M
Stock-Based Compensation
289K363K387K375K436K282K349K000
Deferred Taxes
00-387K-375K-436K-471.2M0000
Other Non-Cash Items
456.06M502.66M56K731K3.92M470.92M284.9M2.16M2.74M2.63M
Working Capital Changes
70.31M-3.26M10.54M-71.61M-105.68M7.83M2.26M1.78M-148.83M-130.88M
Change in Receivables
78.51M1.03M9.29M-72.93M-26.29M-14.44M28.66M32.96M-29.55M-37.6M
Change in Inventory
-1.66M1.2M1.13M-990K-5.42M4.18M283K374K1.29M-360K
Change in Payables
1.44M-4.48M421K4.25M19.78M-17M1.57M-2.69M-2.35M-39.59M
Cash from Investing
-203.23M-51.81M-57.71M2.03M-64.3M-12M-75.94M-88.97M31.18M-1.42M
Capital Expenditures
-68.86M-39.86M-43.71M-36.97M-81.17M-54.12M-46.82M-48.97M-78.82M-68.42M
CapEx % of Revenue
5.87%3.1%4%3.82%6.68%3.4%3.93%4.31%6.76%5.54%
Acquisitions
0384M529.45M349M0319.88M0000
Investments
----------
Other Investing
-134.37M-384M-529.45M-349M-130K-319.88M000-13M
Cash from Financing
-396.02M-391.6M-392.92M-378.2M-344.24M-404.01M-382.23M-396.33M-325.7M-348.8M
Debt Issued (Net)
-120.67M3.65M-77.93M0000000
Equity Issued (Net)
110.7M062.66M0000000
Dividends Paid
-42.12M-53.36M-62.08M-66.36M-66.38M-66.41M-66.42M-66.44M-66.45M-66.46M
Share Repurchases
0000000000
Other Financing
-343.93M-341.89M-315.56M-311.83M-277.86M-337.6M-315.81M-329.9M-259.25M-282.35M
Net Change in Cash
-61.89M▲ 0%
-7.26M▲ 88.3%
179K▲ 102.5%
-2.77M▼ 1646.9%
-97K▲ 96.5%
47.73M▲ 49301.0%
-6.16M▼ 112.9%
-303K▲ 95.1%
-14.05M▼ 4536.0%
-5.33M▲ 0%
Free Cash Flow
468.5M▲ 0%
396.29M▼ 15.4%
407.1M▲ 2.7%
336.43M▼ 17.4%
327.27M▼ 2.7%
409.62M▲ 25.2%
405.18M▼ 1.1%
436.03M▲ 7.6%
201.65M▼ 53.8%
276.47M▲ 0%
FCF Margin %
39.94%30.82%37.28%34.8%26.94%25.71%34.03%38.39%17.28%22.39%
FCF Growth %
4033%-15.41%2.73%-17.36%-2.72%25.16%-1.08%7.61%-53.75%-25.49%
FCF per Share
16.5012.1311.809.569.3011.6311.5012.385.727.80
FCF Conversion (FCF/Net Income)
11.04x8.84x7.39x5.64x4.95x7.23x8.33x7.77x0.94x1.42x
Interest Paid
000000026.53M00
Taxes Paid
0000000831K00

WLKP Key Ratios

Westlake Chemical Partners LP (WLKP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
2.77%2.88%4.68%7.09%8.75%6.84%6.17%7.4%36.6%24.1%
Return on Invested Capital (ROIC)
12.56%12.1%15.26%20.14%23.22%20.11%22.03%24.73%20.59%23.07%
Gross Margin
34.41%29.34%34.75%39.19%36.36%23.69%32.54%36.88%29.81%31.39%
Net Margin
4.15%3.84%5.58%6.84%6.79%4.03%4.56%5.49%25.59%15.8%
Debt / Equity
0.27x0.29x0.42x0.44x0.41x0.44x0.47x0.48x0.50x0.50x
Interest Coverage
17.21x16.42x18.00x29.38x46.59x26.05x13.66x15.40x14.06x10.26x
FCF Conversion
11.04x8.84x7.39x5.64x4.95x7.23x8.33x7.77x0.94x1.42x
Revenue Growth
18.87%9.6%-15.07%-11.47%25.67%31.14%-25.26%-4.61%2.71%13.4%
Related:WLKP Dividend History·WLKP Revenue History·WLKP Price History·WLKP P/E History·WLKP Financial Ratios·WLKP Institutional Holders

WLKP SEC Filings & Documents

Westlake Chemical Partners LP (WLKP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 20, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

5
FY 2026

Mar 4, 2026·SEC

FY 2025

Mar 5, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 6, 2025·SEC

WLKP Frequently Asked Questions

Westlake Chemical Partners LP (WLKP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Westlake Chemical Partners LP (WLKP) reported $1.23B in revenue for fiscal year 2025. This represents a 45% decrease from $2.25B in 2012.

Westlake Chemical Partners LP (WLKP) grew revenue by 2.7% over the past year. Growth has been modest.

Yes, Westlake Chemical Partners LP (WLKP) is profitable, generating $195.1M in net income for fiscal year 2025 (25.6% net margin).

Dividend & Returns

Yes, Westlake Chemical Partners LP (WLKP) pays a dividend with a yield of 8.35%. This makes it attractive for income-focused investors.

Westlake Chemical Partners LP (WLKP) has a return on equity (ROE) of 36.6%. This is excellent, indicating efficient use of shareholder capital.

Westlake Chemical Partners LP (WLKP) generated $276.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in WLKP back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →

How much would $100/month in WLKP be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →